Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.64
+ 0.10 (+6.48%)
Day High: 1.67
Day Low:  1.51
Volume:    675,151
3:36 PM ET on Apr 28, 2017

Delayed at least 20 minutes.